menu

Medical Industry Feature: What are the Clinical Implications of JAK & IL-23 Pathways in Psoriatic Arthritis?

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

What are the Clinical Implications of JAK & IL-23 Pathways in Psoriatic Arthritis?

What are the Clinical Implications of JAK & IL-23 Pathways in Psoriatic Arthritis?
RestartResume
    This video shows the current understanding of the role of JAKs and IL-23 involved in the pathogenesis of psoriatic arthritis.
    • Sponsored by

    • Overview

      Patients with psoriatic arthritis (PsA) have a variety of articular symptoms, as well as a  higher prevalence of comorbidities associated with systemic inflammation, such as cardiovascular disease and metabolic syndrome.

      This video shows the current understanding of the role of Janus kinases (JAKs) and IL-23 in cytokine signaling pathways involved in the pathogenesis of psoriatic arthritis. 

      This activity is intended for United States and Puerto Rico health care professionals only and was developed by AbbVie. 

    You must be in to display playlists.

    Get a Dose of ReachMD in Your Inbox
    and Practice Smarter Medicine

    Stay current with the best in medical education.